Table 2 Different clinicopathological characteristics in the recurrent group and the non-recurrent group of TNBC patients
Characteristic | Non-recurrent group [cases (%)] | Recurrent group [cases (%)] | P value |
|---|---|---|---|
Total | 235 | 81 | |
Age (years) | 0.768 | ||
≤ 40 | 56 (23.8) | 18 (6.7) | |
> 40 | 179 (76.2) | 63 (77.8) | |
Family history of breast cancer | 0.396 | ||
Yes | 35 (14.9) | 9 (11.1) | |
No | 200 (85.1) | 72 (88.9) | |
T stage | 0.199 | ||
pT0–T1 | 121 (51.5) | 35 (43.2) | |
pT2–T4 | 114 (48.5) | 46 (56.8) | |
Axillary lymph node status | < 0.001 | ||
Negative | 163 (69.4) | 36 (44.4) | |
Positive | 72 (30.6) | 45 (55.6) | |
TNM stage | < 0.001 | ||
0–I | 91 (38.7) | 18 (22.2) | |
II–III | 144 (61.3) | 63 (77.8) | |
Pathological type | 0.407 | ||
Invasive ductal carcinoma | 217 (92.3) | 77 (95.0) | |
Grade 1/2 | 75 (31.9) | 34 (42.0) | |
Grade 3 | 131 (55.7) | 33 (40.7) | |
Unknown | 11 (4.7) | 10 (12.3) | |
Others | 18 (7.7) | 4 (5.0) | |
Vascular invasion | 0.003 | ||
Yes | 26 (11.1) | 20 (24.7) | |
No | 209 (88.9) | 61 (75.3) | |
Adjuvant radiotherapy | 0.429 | ||
Yes | 87 (37.0) | 34 (42.0) | |
No | 148 (63.0) | 47 (58.0) | |
ATG5 rs473543 genotype | 0.024 | ||
AA | 46 (19.6) | 14 (17.3) | |
GA | 97 (41.3) | 47 (58.0) | |
GG | 92 (39.1) | 20 (24.7) | |